Key result
Genetic ablation of leene in mice exacerbates AngII-induced hypertension and aggravates cardiorenal hypertrophy and fibrosis.
Why the study?
The role of the lncRNA LEENE (transcribed from LINC00520) in blood pressure regulation was unknown.
Does genetic deletion of the LINC00520 homolog (leene) aggravate Angiotensin II-induced hypertension and end-organ damage in mice?
Does genetic deletion of the LINC00520 homolog (leene) aggravate Angiotensin II-induced hypertension and end-organ damage in mice?
Genetic deletion of the LEENE/LINC00520 homolog exacerbates Angiotensin II-induced hypertension and end-organ damage in mice, suggesting a role for LEENE in blood pressure regulation via endothelial cell function.
(1) Background: Hypertension is a complex, multifactorial disease that is caused by genetic and environmental factors. Apart from genetic predisposition, the mechanisms involved in this disease have yet to be fully understood. We previously reported that LEENE (lncRNA enhancing endothelial nitric oxide expression, transcribed from LINC00520 in the human genome) regulates endothelial cell (EC) function by promoting the expression of endothelial nitric oxide synthase (eNOS) and vascular growth factor receptor 2 (VEGFR2). Mice with genetic deletion of the LEENE/LINC00520 homologous region exhibited impaired angiogenesis and tissue regeneration in a diabetic hindlimb ischemia model. However, the role of LEENE in blood pressure regulation is unknown. (2) Methods: We subjected mice with genetic ablation of leene and wild-type littermates to Angiotensin II (AngII) and monitored their blood pressure and examined their hearts and kidneys. We used RNA-sequencing to identify potential leene-regulated molecular pathways in ECs that contributed to the observed phenotype. We further performed in vitro experiments with murine and human ECs and ex vivo experiments with murine aortic rings to validate the select mechanism. (3) Results: We identified an exacerbated hypertensive phenotype of leene-KO mice in the AngII model, evidenced by higher systolic and diastolic blood pressure. At the organ level, we observed aggravated hypertrophy and fibrosis in the heart and kidney. Moreover, the overexpression of human LEENE RNA, in part, restored the signaling pathways impaired by leene deletion in murine ECs. Additionally, Axitinib, a tyrosine kinase inhibitor that selectively inhibits VEGFR suppresses LEENE in human ECs. (4) Conclusions: Our study suggests LEENE as a potential regulator in blood pressure control, possibly through its function in ECs.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2023) studied Angiotensin II-induced hypertension. Genetic ablation of leene vs. Wild-type littermates was evaluated on Blood pressure (systolic and diastolic), hypertrophy, and fibrosis. Genetic ablation of leene in mice exacerbated Angiotensin II-induced hypertension, evidenced by higher systolic and diastolic blood pressure and aggravated heart and kidney hypertrophy and fibrosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: